Saro H. Armenian - Concepedia

Author

Saro H. Armenian

Also Known As

Armenian, Saro, Ghassan Abou-Alfa, S Armenian, S H Armenian, S. Armenian, S. H. Armenian, S.H. Armenian, Saro Armenian, Saro H Armenian, Saro H. Armenian

475

Publications

13.7K

Citations

H-Index

120

Concepts

All Affiliations

City of Hope University of Alabama at Birmingham City Of Hope National Medical Center Fred Hutch Cancer Center St. Jude Children's Research Hospital

About

Saro H. Armenian is an author at City of Hope specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	31	4.4K
2	Health Sciences	6	6	254
3	Education	3	3	216
4	Arts	1	1	355
5	Engineering	1	1	36

Saro H. Armenian

129

Publications

10K

Citations

H-Index

Page 1

	Year	Citations
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline Saro H. Armenian, Christina Lacchetti, Ana Barac, Journal of Clinical Oncology Heart FailureAdult Cardiac SurgeryAmerican SocietyCardiac DysfunctionPreventive Cardiology	2017	1.2K
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations Giuseppe Curigliano, Daniel J. Lenihan, Michael G. Fradley, Annals of Oncology OncologyCardiovascular DiseaseCardiac DiseaseEsmo Consensus RecommendationsCancer Management	2020	950
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement Joerg Herrmann, Daniel J. Lenihan, Saro H. Armenian, European Heart Journal Heart FailureOncologyCardiovascular ToxicitiesCardiovascular DiseaseAtherosclerosis	2021	542
Cardiovascular Disease Among Survivors of Adult-Onset Cancer: A Community-Based Retrospective Cohort Study Saro H. Armenian, Lanfang Xu, Bonnie Ky, Journal of Clinical Oncology	2016	520
A worldwide collaboration to harmonize guidelines for the long‐term follow‐up of childhood and young adult cancer survivors: A report from the international late effects of Childhood Cancer Guideline Harmonization Group Leontien C.M. Kremer, Renée L. Mulder, Kevin C. Oeffinger, Pediatric Blood & Cancer Palliative CareFamily MedicineWorldwide CollaborationHealth PolicyInternational Late Effects	2012	355
Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease Saro H. Armenian, Can‐Lan Sun, Tabitha Vase, Blood	2012	216
Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS) Saro H. Armenian, Can-Lan Sun, Toana Kawashima, Blood	2011	200
Cardiovascular Disease Risk Profiles in Survivors of Adolescent and Young Adult (AYA) Cancer: The Kaiser Permanente AYA Cancer Survivors Study Chun Chao, Lanfang Xu, Robert Cooper, Journal of Clinical Oncology	2016	198
Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children’s Oncology Group Randomized Trial Pediatric Oncology Group 9404 Barbara L. Asselin, Meenakshi Devidas, Lu Chen, Journal of Clinical Oncology	2015	196
Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation Saro H. Armenian, Can‐Lan Sun, Tabitha Shannon, Blood	2011	162

Page 1